Panion & BF Biotech Inc
TWSE:1760

Watchlist Manager
Panion & BF Biotech Inc Logo
Panion & BF Biotech Inc
TWSE:1760
Watchlist
Price: 65.9 TWD -0.9% Market Closed
Market Cap: 5.7B TWD

Panion & BF Biotech Inc
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Panion & BF Biotech Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Panion & BF Biotech Inc
TWSE:1760
Cash from Operating Activities
NT$351m
CAGR 3-Years
-4%
CAGR 5-Years
31%
CAGR 10-Years
17%
Y
YungShin Global Holding Corp
TWSE:3705
Cash from Operating Activities
NT$1.4B
CAGR 3-Years
13%
CAGR 5-Years
3%
CAGR 10-Years
5%
ScinoPharm Taiwan Ltd
TWSE:1789
Cash from Operating Activities
NT$506.9m
CAGR 3-Years
-16%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Cash from Operating Activities
NT$7.7B
CAGR 3-Years
52%
CAGR 5-Years
37%
CAGR 10-Years
33%
Standard Chem & Pharm Co Ltd
TWSE:1720
Cash from Operating Activities
NT$1.8B
CAGR 3-Years
13%
CAGR 5-Years
19%
CAGR 10-Years
12%
C
Caliway Biopharmaceuticals Co Ltd
TWSE:6919
Cash from Operating Activities
-NT$522m
CAGR 3-Years
-68%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
No Stocks Found

Panion & BF Biotech Inc
Glance View

Market Cap
5.7B TWD
Industry
Pharmaceuticals

Panion & BF Biotech, Inc. engages in the manufacturing and sales of medicines, cosmetics, and formula foods. The company is headquartered in Taipei City, Taipei. The company went IPO on 2004-06-14. The firm is also involved in the manufacture and sales of various kinds of cosmetics. The firm's products also include formula food, medical devices, animal drugs, pet drugs, feed and environmental health drugs. The firm also provides biotechnology services. The firm distributes its products in Taiwan market and to the mainland China, Hong Kong and Macau markets.

Panion & BF Biotech Inc Intrinsic Value
HIDDEN
Show

See Also

What is Panion & BF Biotech Inc's Cash from Operating Activities?
Cash from Operating Activities
351m TWD

Based on the financial report for Dec 31, 2024, Panion & BF Biotech Inc's Cash from Operating Activities amounts to 351m TWD.

What is Panion & BF Biotech Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
17%

Over the last year, the Cash from Operating Activities growth was 98%. The average annual Cash from Operating Activities growth rates for Panion & BF Biotech Inc have been -4% over the past three years , 31% over the past five years , and 17% over the past ten years .

Back to Top